Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

5281 - Stemness in hepatocellular carcinoma reduced by inhibition of WEE1 expression

Date

21 Oct 2018

Session

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

Topics

Translational Research

Tumour Site

Hepatobiliary Cancers

Presenters

Keon Uk Park

Citation

Annals of Oncology (2018) 29 (suppl_8): viii205-viii270. 10.1093/annonc/mdy282

Authors

K.U. Park1, M.J. Ko2, H.M. Ryoo3, Y. Lee4

Author affiliations

  • 1 Oncology, Dongsan Medical Center Kemyung University Hospital, 700-712 - Daegu/KR
  • 2 Department Of Hematology/oncology, Keimyung University School of Medicine, 700712 - Daegu/KR
  • 3 Hematology/oncology, Daegu Catholic University, 700712 - Daegu/KR
  • 4 Department Of Molecular Biology, Keimyung University School of Medicine, 700712 - Daegu/KR
More

Resources

Abstract 5281

Background

Chemotherapy targets proliferating cells, not cancer stem cells (CSCs). Targeting agents, e.g. sorafenib for hepatocellular carcinoma (HCC), do not seem to target CSCs as evidenced by frequent tumor relapse and resistance after therapy. Identification and characterization of signaling pathways and biomarkers associated with CSC biology are priorities for developing new paradigms of molecular cancer therapeutics. Increase of WEE1 kinase activity through an epigenetic regulation plays an important role in the development of HCC. However, the functional role of WEE1 in HCC progression remains to be clarified.

Methods

Human HCC cell lines were transfected with WEE1 siRNA and tested for growth inhibition, apoptotic induction, molecular changes in both RNA and protein levels, and changes in CSC phenotype using various methods such as MTS, FACS, microscopic analysis, Real-time PCR, Western blotting, sphere forming assay. To find the molecular changes in response to WEE1 knockdown, global changes in gene expression were examined using RNA sequencing.

Results

We demonstrated that WEE1 siRNA silencing caused inhibition of HCC cell growth through blockade of cell cycle progression and induction of apoptosis. The anti-proliferative effects were driven by a subset of molecular alterations including the upregulation of cdk inhibitor p21 and the downregulation of AKT1, CDK2, cyclin B1, PARP1 and GPAM which are functionally involved in control of cell cycle, apoptosis and lipid metabolism. WEE1 silencing resulted in a strong inhibition of lipogenesis and caused a marked decrease in fat accumulation. Knockdown of WEE1 dramatically reduced the portion of liver CSC population through co-downregulation of cancer stemness genes, weakened the capacity of sphere formation and cancer cell migration. Systemic delivery of a modified WEE1 siRNA encapsulated in lipid nanoparticles nhibited human HCC growth in murine xenograft models, and increased survival.

Conclusions

Our findings suggest that the epigenetic modifier WEE1 functionally involve to HCC lipid metabolism and CSC-like phenotype maintenance and that molecular targeting of WEE1 may be an effective systemic therapy for prevention of tumor recurrence via elimination of CSCs in liver tumor microenvironment.

Clinical trial identification

Legal entity responsible for the study

Keon Uk Park.

Funding

Has not received any funding.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.